• 1
    Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 1998; 8:397403.
  • 2
    Donohue T. The ubiquitin-proteasome system and its role in ethanol-induced disorders. Addition Biology 2002; 7:1528.
  • 3
    Baraona E, Leo MA, Borowsky SA, Lieber CS. Pathogenesis of alcohol-induced accumulation of protein in the liver. J Clin Invest 1977; 60:546554.
  • 4
    Fataccioli V, Andraud E, Gentil M, French SW, Rouach H. Effects of chronic ethanol administration on rat liver proteasome activities: relationship with oxidative stress. Hepatology 1999; 29:1420.
  • 5
    Takagi M, Yamauchi M, Toda G, Takada K, Hirakawa T, Ohkawa K. Serum ubiquitin levels in patients with alcoholic liver disease. Alcohol Clin Exp Res 1999; 23:76S80S.
  • 6
    Bardag-Gorce F, van Leeuwen FW, Nguyen V, French BA, Li J, Riley N, McPhaul LW, et al. The role of the ubiquitin-proteasome pathway in the formation of Mallory bodies. Exp Mol Pathol 2002; 73:7583.
  • 7
    French BA, van Leeuwen F, Riley NE, Yuan QX, Bardag-Gorce F, Gaal K, Lue YH, et al. Aggresome formation in liver cells in response to different toxic mechanisms: role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin. Exp Mol Pathol 2001; 71:241246.
  • 8
    Perez MJ, Cederbaum AI. Proteasome inhibition potentiates CYP2E1-mediated toxicity in HepG2 cells. Hepatology 2003; 37:13951404.
  • 9
    Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol 2002; 7:2327.
  • 10
    Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol 2002; 72:847855.
  • 11
    Jaeschke H, Mullen KD, Moradpour D. Comments. Inflammation in response to hepatocellular apoptosis. Hepatology 2002; 35:964965.
  • 12
    Hill DB, Marsano L, McClain CJ. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology 1993; 18:576580.
  • 13
    Hill DB, Schmidt J, Shedlofsky SI, Cohen DA, McClain CJ. In vitro tumor necrosis factor cytotoxicity in Hep G2 liver cells. Hepatology 1995; 21:11141119.
  • 14
    Dooley DC, Simpson JF, Meryman HT. Isolation of large numbers of fully viable human neutrophils: a preparative technique using Percoll density gradient centrifugation. Exp Hematol 1982; 10:591599.
  • 15
    Nanjii AA, Su GL, Laposata M, French SW. Pathogenesis of alcoholic liver disease—recent advances. Alcohol Clin Exp Res 2002; 26:731736.
  • 16
    Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002; 65:166176.
  • 17
    Cederbaum AI, Wu D, Mari M, Bai J. CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free Radic Biol Med 2001; 31:15391543.
  • 18
    Schuchmann M, Galle PR. Apoptosis in liver disease. Eur J Gastroenterol Hepatol 2001; 13:785790.
  • 19
    Deaciuc IV, D'Souza NB, de Villiers WJ, Burikhanov R, Sarphie TG, Hill DB, McClain CJ. Inhibition of caspases in vivo protects the rat liver against alcohol-induced sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 2001; 25:935943.
  • 20
    Deaciuc IV, Fortunato F, D'Souza NB, Hill H, McClain CJ. Chronic alcohol exposure of rats exacerbates apoptosis in hepatocytes and sinusoidal endothelial cells. Hepatol Res 2001; 19:306334.
  • 21
    Jaeschke H, Fisher MA, Lawson JA, Simmons CA, Farhood A, Jones DA. Activation of caspase-3 (CPP32)-like proteases is essential for TNF-α-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J Immunol 1998; 160:34803486.
  • 22
    Lawson JA, Fisher MA, Simmons CA, Farhood A, Jaeschke H. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin- and Fas-antibody-mediated liver injury. Hepatology 1998; 28:761767.
  • 23
    Faouzi S, Burckhardt BE, Hanson JC, Campe CB, Schrum LW, Rippe RA, Maher JJ. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-κB-independent, caspase-3-dependent pathway. J Biol Chem 2001; 276:4907749082.
  • 24
    Thornton AJ, Ham J, Kunkel SL. Kupffer cell-derived cytokines induce the synthesis of a leukocyte chemotactic peptide, interleukin-8, in human hepatoma and primary hepatocyte cultures. Hepatology 1991; 14:11121122.
  • 25
    Sheron N, Bird G, Koskinas J, Portmann B, Ceska M, Lindley I, Williams R. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993; 18:4146.
  • 26
    McClain CJ, Hill DB, Song Z, Dezciuc I, Barve S. Monocyte activation in alcoholic liver disease. Alcohol 2002; 27:5361.
  • 27
    Mosher B, Dean R, Harkema J, Remick D, Palma J, Crockett E. Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. J Surg Res 2001; 99:201210.
  • 28
    Maher JJ, Scott MK, Saito JM, Burton MC. Adenovirus-mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis. Hepatology 1997; 25:624630.
  • 29
    Zoli M, Tepper M, Lohez M, Arcangeli G, Ganne N, Christidis C, Trinchet J-C, et al. Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol 2001; 34:254260.
  • 30
    Rogers HW, Callery MP, Deck B, Unanue ER. Listeria monocytogenes induces apoptosis of infected hepatocytes. J Immunol 1996; 156:679684.
  • 31
    Schäfer T, Scheuer C, Roemer K, Menger MD, Vollmar B. Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death. FASEB J 2003; 17:660667.
  • 32
    Mastronarde JG, Monick MM, Mukaida N, Matsushima K, Hunninghake GW. Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-κB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium. J Infect Dis 1998; 177:12751281.
  • 33
    Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A 1993; 90:1019310197.
  • 34
    Fiedler MA, Wernke-Dollries K, Stark JM. Inhibition of TNF-alpha-induced NF-κB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132. Am J Respir Cell Mol Biol 1998; 19:259268.
  • 35
    Elliott CL, Allport VC, Loudon JA, Wu GD, Bennett PR. Nuclear factor-κB is essential for up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells. Mol Hum Reprod 2001; 7:787790.
  • 36
    Wang Q, Dziarski R, Kirschning CJ, Muzio M, Gupta D. Micrococci and peptidoglycan activate TLR2[RIGHTWARDS ARROW]MyD88[RIGHTWARDS ARROW]IRAK[RIGHTWARDS ARROW]TRAF[RIGHTWARDS ARROW]NIK[RIGHTWARDS ARROW]IKK[RIGHTWARDS ARROW]NF-κB signal transduction pathway that induces transcription of interleukin-8. Infect Immun 2001; 69:22702276.
  • 37
    Mahieux R, Lambert PF, Agbottah E, Halanski MA, Deng L, Kashanchi F, Brady JN. Cell cycle regulation of human interleukin-8 gene expression by the human immunodeficiency virus type 1 Tat protein. J Virol 2001; 75:17361743.
  • 38
    Lakshminarayanan V, Drab-Weiss EA, Roebuck KA. H2O2 and tumor necrosis factor-α induce differential binding of the redox-responsive transcription factors AP-1 and NF-κB to the interleukin-8 promoter in endothelial and epithelial cells. J Biol Chem 1998; 273:3267032678.
  • 39
    Roebuck KA. Regulation of IL-8 gene expression. J Interferon Cytokine Res 1999; 19:429438.
  • 40
    DeForge LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, Remick DG. Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem 1993; 268:2556825576.
  • 41
    Kim J, Sanders SP, Siekierski ES, Casolaro V, Proud D. Role of NF-κB in cytokine production induced from human airway epithelial cells by rhinovirus infection. J Immunol 2000; 165:33843392.
  • 42
    Jaspers I, Samet JM, Reed W. Arsenite exposure of cultured airway epithelial cells activates κB-dependent interleukin-8 gene expression in the absence of nuclear factor-κB nuclear translocation. J Biol Chem 1999; 274:3102531033.
  • 43
    Hipp MS, Urbich C, Mayer P, Wischhusen J, Weller M, Kracht M, Spyridopoulos I. Proteasome inhibition leads to NF-κB-independent IL-8 transactivation in human endothelial cells through induction of AP-1. Eur J Immunol 2002; 32:22082217.
  • 44
    Wu HM, Wen HC, Lin WW. Proteasome inhibitors stimulate interleukin-8 expression via Ras and apoptosis signal-regulating kinase-dependent extracellular signal-related kinase and c-Jun Nterminal kinase activation. Am J Respir Cell Mol Biol. 2002; 27:234243.